ThreadEast
Society trends / The Paper

Patient Death in Clinical Trial Raises Questions About CAR-T Risks and Informed Consent

View original Chinese title

临床入组患者死亡，“神药”CAR-T祛魅：“临床试验”风险有多大？有无充分告知患者？

Read original on The PaperChinese source · opens in a new tab

The story

An English article summary is not available yet. Read the original on The Paper

Go to the source

Original articles & discussion

For the source’s own discussion, open the original above. No verified comment translations are available here yet.

Ranking history & source details

First recorded Sep 5, 2026, 8:51 AM CST · latest Sep 5, 2026, 8:16 PM CST. Ranks reflect attention on each platform.

Retained daily observations
DayPlatformBest rankLast rank
2026-09-05The Paper#2#2
How rankings are collected

More society trends

Zhang Xue says she blocked her mother on WeChat and angrily accuses an institution of treating her family as a source of trafficIf an employee seeks 2N compensation for unlawful dismissal in labor arbitration but loses, can they still change the claim to N economic compensation in the first trial?Why do some parents keep lecturing their children day after day even though they know reasoning with them repeatedly is ineffective and goes unheard?Twenty-three-year-old cancer influencer Xiaxia dies after being diagnosed with osteosarcoma at 18; her parents lost contact after her amputation—how should her cancer journey be viewed, and what kind of disease is osteosarcoma?